Bone health in asthma: a twofold effect of disease and pharmacotherapy - Takeaways - MDSpire

Bone health in asthma: a twofold effect of disease and pharmacotherapy

  • By

  • Sidian Yang

  • Yihao Wang

  • Xingchao Li

  • Yewen Niu

  • Liming Lei

  • Zichao Han

  • June 2, 2026

  • 0 min

Share

  • 1

    Asthma is a chronic inflammatory airway disease affecting approximately 260 million individuals globally.

  • 2

    Chronic inflammation in asthma disrupts bone metabolism, enhancing bone resorption and suppressing formation.

  • 3

    Long-term glucocorticoid therapy significantly lowers bone mineral density and increases fracture risk.

  • 4

    Vitamin D deficiency and physical inactivity further impair bone health in individuals with asthma.

  • 5

    Multidisciplinary collaboration is essential for managing asthma while preserving bone health.

Original Source(s)

Bone health in asthma: a twofold effect of disease and pharmacotherapy

  • by Sidian Yang, Yihao Wang, Xingchao Li, Yewen Niu, Liming Lei, Zichao Han

  • June 2, 2026

Related Content

A dynamic vascular–inflammatory–fibrotic loop in systemic sclerosis: an integrative immuno-vascular framework

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

Nozart Breaks Down Asthma Education Barriers